Autoantibodies to protein transport and messenger RNA processing pathways: Endosomes, lysosomes, Golgi complex, proteasomes, assemblyosomes, exosomes, and GW bodies

Clinical Immunology

Volumn 110, Issue 1, 2004, Pages 30-44

  Stinton, Laura M ^a   Eystathioy, Theophany ^a   Selak, Sanja ^b   Chan, Edward K L ^c   Fritzler, Marvin J ^a  

^a UNIVERSITY OF CALGARY   (Canada)

^b INSTITUTO CAJAL   (Spain)

^c UNIVERSITY OF FLORIDA COLLEGE OF DENTISTRY   (United States)

Author keywords

Autoantibodies; Autoimmunity; Endosome; Lysosome; Proteasome; Review

Indexed keywords

AUTOANTIBODY; CYSTEINE PROTEINASE; MESSENGER RNA; MULTIENZYME COMPLEX; PROTEASOME;

ANALYTIC METHOD; ANIMAL; CYTOPLASM; ENDOSOME; GOLGI COMPLEX; HUMAN; IMMUNOLOGY; LABORATORY; LYSOSOME; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEIN STRUCTURE; PROTEIN TRANSPORT; REVIEW; RNA PROCESSING; SIGNAL TRANSDUCTION;

EID: 0842303167     PISSN: 15216616     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clim.2003.10.005     Document Type: Article

References (198)

1. Tan E.M. Autoantibodies in pathology and cell biology. Cell. 67:1991;841-842.
2. von Muhlen C.A., Tan E.M. Autoantibodies in the diagnosis of systemic rheumatic disease. Semin. Arthritis Rheum. 24:1995;323-358.
3. Fritzler M.J. Clinical relevance of autoantibodies in systemic rheumatic diseases. Mol. Biol. Rep. 23:1996;133-145.
4. McMillan S.A., Alderdice J.M., McKee C.M., Dawson A.T., Callender M.E., Fulton T.T., Haire M. Diversity of autoantibodies in patients with antimitochondrial antibody and their diagnostic value. J. Clin. Pathol. 40:1987;232-236.
5. Fritzler M.J., Manns M.P. Anti-mitochondrial antibodies. Clin. Appl. Immunol. Rev. 3:2002;87-113.
6. Leung P.S.C., Coppel R.L., Gershwin M.E. Mitochondrial antibodies. Peter J.B., Shoenfeld Y. Autoantibodies. 1996;494-500 Elsevier, New York.
7. Caldwell S.H., Leung P.S., Spivey J.R., Prindiville T., de Mdeina M., Saicheur T., Rowley M., Reddy K.R., Coppel R., Jeffers L.J.et al. Antimitochondrial antibodies in kindreds of patients with primary biliary cirrhosis: antimitochondrial antibodies are unique to clinical disease and are absent in asymptomatic family members. Hepatology. 16:1992;899-905.
8. Chan E.K.L., Fritzler M.J. Autoantibodies to Golgi apparatus antigens. Conrad K., Humbel R.-L., Meurer M., Shoenfeld Y., Tan E.M. Pathogenic and Diagnostic Relevance of Autoantibodies. Proceedings 4th Dresden Symposium on Autoantibodies. 1998;85-100 Pabst Scientific Publishers, Scottsdale, AZ.
9. Chan E.K.L., Fritzler M.J. Golgins: coiled-coil-rich proteins associated with the Golgi complex. Elect. J. Biotechnol. 1:1998;. ( http://ejb.ucv.cl/ content/vol1/issue2/full/1 ).
10. Rattner J.B., Fritzler M.J. Centriole and centrosome autoantibodies. Peter J.B., Shoenfeld Y. Autoantibodies. 1996;153-160 Elsevier, The Netherlands.
11. Gavanescu D., Vasquez-abad, McCauley J., Senécal J.-L, Doxsey S. Centrosome proteins: a major class of autoantigens in scleroderma. J. Clin. Immunol. 19:1999;166-171.
12. Balczon R. Autoantibodies as probes in cell and molecular biology. Proc. Soc. Exp. Biol. Med. 204:1993;138-154.
13. Teh L.S., Isenberg D.A. Antiribosomal P protein antibodies in systemic lupus erythematosus. A reappraisal. Arthritis Rheum. 37:1994;307-315.
14. Griffith K.J., Chan E.K.L., Hamel J.C., Miyachi K., Fritzler M.J. Molecular characterization of a novel 97 kDa Golgi complex autoantigen recognized by autoimmune antibodies from patients with Sjögren's syndrome. Arthritis Rheum. 40:1997;1693-1702.
15. Fritzler M.J., Lung C.-C., Hamel J.C., Griffith K., Chan E.K.L. Molecular characterization of golgin-245: a novel Golgi complex protein containing a granin signature. J. Biol. Chem. 270:1995;31262-31268.
16. Mu F.T., Callaghan J.M., Steele-Mortimer H.S., Parton R.G., Campbell P.L., McCluskey J., Yeo J.P., Tock E.P.C., Toh B.H. EEA1, an early endosomal protein. J. Biol. Chem. 270:1995;13503-13511.
17. Selak S., Schoenroth L., Senécal J.-L., Fritzler M.J. Early endosome antigen 1: an autoantigen associated with neurological diseases. J. Invest. Med. 47:1999;311-318.
18. Kain R., Matsui K., Exner M., Binder S., Schaffner G., Sommer E.M., Kerjaschki D. A novel class of autoantigens of anti-neutrophil cytoplasmic antibodies in necrotizing and crescentic glomerulonephritis: the lysosomal membrane glycoprotein h-lamp-2 in neutrophil granulocytes and a related membrane protein in glomerular endothelial cells. J. Exp. Med. 181:1995;585-597.
19. Feist E., Dörner T., Kuckelkorn U., Scheffler S., Burmester G.R., Kloetzel P.M. Diagnostic importance of anti-proteasome antibodies. Int. Arch. Allergy Immunol. 123:2000;92-97.
20. Feist E., Schneider M.L., Brychcy M., Dörner T., Burmester G.R., Hiepe F. A unique autoantibody pattern of positive anti-Jo-1, anti-U1RNP, and antiproteasome antibodies in autoimmune myositis as a diagnostic challenge. Ann. Rheum. Dis. 62:2003;370-371.
21. Brouwer R., Pruijn G.J.M., Van Venrooij J.V. The human exosome: an autoantigenic complex of exoribonucleases in myositis and scleroderma. Arthritis Res. 3:2001;102-106.
22. Brouwer R., Egberts W.V., Hengstman G.J.D., Rajimakers R., van Engelen B.G.M., Seelig H.P., Renz M., Mierau R., Genth E., Pruijn G.J.M., Van Venrooij J.V. Autoantibodies directed to novel components of the PM/Scl complex, the human exosome. Arthritis Res. 4:2002;134-138.
23. Eystathioy T., Chan E.K.L., Tenenbaum S.A., Keene J.D., Griffith K.J., Fritzler M.J. A phosphorylated cytoplasmic autoantigen, GW182, associates with a unique population of human mRNAs within novel cytoplasmic speckles. Mol. Biol. Cell. 13:2002;1338-1351.
24. Eystathioy T., Chan E.K.L., Yang Z., Takeuchi K., Mahler M., Luft L.M., Zochodne D.W., Fritzler M.J. Clinical and serological associations of autoantibodies to a novel cytoplasmic autoantigen, GW182 and GW bodies. J. Mol. Med. 2003;. (in press).
25. Hughes G.R.V., Asherson R.A. Atypical lupus with special reference to ANA negative lupus and lupus subsets. Adv. Nephrol. 14:1985;333-346.
26. Reichlin M. ANA negative systemic lupus erythematosus sera revisited serologically. Lupus. 9:2000;116-119.
27. Fritzler M.J., Wiik A., Fritzler M.L., Barr S.G. The use and abuse of commercial kits used to detect autoantibodies. Arthritis Res. Ther. 5:2003;192-201.
28. Tan E.M., Feltkamp E.W., Butcher B., Conn D.L., McDougal J.S., Dawkins R., Fritzler M.J., Gordon T.P., Kalden J.R., Hardin J., Lahita R., Maini R.N., Rothfield N.F., Smeenk R., Takasaki Y., Van Venrooij W., Wiik A., Wilson M., Koziol J.A. A critical evaluation of enzyme immunoassays for the detection of antinuclear antibodies of defined specificities: I. Precision, sensitivity and specificity. Arthritis Rheum. 42:2000;455-464.
29. Tan E.M., Smolen J.S., McDougal J.S., Klippel J.H., Fritzler M.J., Gordon T.P., Hardin J.A., Kalden J.R., Lahita R.G., Maini R.N., Rothfield N.F., Takasaki Y., Wiik A., Wilson M.R., Koziol J.A. A critical evaluation of enzyme immunoassay kits for the detection of antinuclear antibodies of defined specificities: II. Potential for quantitation of antibody content. J. Rheumatol. 29:2002;68-74.
30. Fritzler M.J., Wiik A., Tan E.M., Smolen J.S., McDougal J.S., Chan E.K.L., Gordon T.P., Hardin J.A., Kalden J.R., Lahita R.G., Maini R.N., Reeves W.H., Rothfield N.F., Takasaki Y., Wilson M., Byrd M., Slivka L., Koziol J.A. A critical evaluation of enzyme immunoassay kits for detection of antinuclear antibodies of defined specificities: III. Comparative performance characteristics of academic and manufacturers' laboratories. J. Rheumatol. 30:2003;2374-2381.
31. Fritzler M.J., Hanson C., Miller J., Eystathioy T. Specificity of autoantibodies to SS-A/Ro on a transfected and overexpressed human 60 kDa Ro autoantigen substrate. J. Clin. Lab. Anal. 16:2002;103-108.
32. Cordiali F.P., D'Agosto G., Ameglio F., Valesini G., Alessandri C., Farsi A., Domenighetti M.P., Passaleva A., Scamardella F., Neri R., Bombardieri S., Quinzanini M., Franceschini F., Chiarotti F. Determination of antibodies to extractable nuclear antigens by commercial kits: a multicenter study. Int. J. Clin. Lab. Res. 28:1998;29-33.
33. Prince H.E., Hogrefe W.R. Evaluation of a line immunoassay for detection of antibodies recognizing extractable nuclear antigens. J. Clin. Lab. Anal. 12:1998;320-324.
34. Meheus L., Van Venrooij W.J., Wiik A., Charles P.J., Tzioufas A.G., Meyer O., Steiner G., Gianola D., Bombardieri S., Union A., De Keyser S., Veys E., De Keyser F. Multicenter validation of recombinant, natural and synthetic antigens used in a single multiparameter assay for the detection of specific anti-nuclear antibodies in connective tissue disorders. Clin. Exp. Rheumatol. 17:1999;205-214.
35. Selak S., Mahler M., Miyachi K., Fritzler M.L., Fritzler M.J. Identification of the B-cell epitopes of the early endosome antigen 1 (EEA1). Clin. Immunol. 109:2003;154-164. (in press).
36. Mahler M., Kessenbrock K., Raats J., Williams R.C. Jr., Fritzler M.J. Characterization of the human autoimmune response to the major C-terminal epitope of the ribosomal P proteins. J. Mol. Med. 81:2003;194-204.
37. Griffith K.J., Ryan J.P., Senécal J.-L., Fritzler M.J. The cytoplasmic linker protein CLIP-170 is a human autoantigen. Clin. Exp. Immunol. 127:2002;533-538.
38. Wiik A. Autoantibodies in vasculitis. Arthritis Res. Ther. 5:2003;147-152.
39. Stenmark H., Aasland R., Toh B.H., D'Arrigo A. Endosomal localization of the autoantigen EEA1 is mediated by a zinc-binding FYVE finger. J. Biol. Chem. 271:1996;24048-24054.
40. Callaghan J., Simonsen A., Gaullier J.M., Toh B.H., Stenmark H. The endosome fusion regulator early-endosomal autoantigen 1 (EEA1) is a dimer. Biochem. J. 338:1999;539-543.
41. Patki V., Virbasius J., Lane W.S., Toh B.-H., Shpetner H.S., Corvera S. Identification of an early endosomal protein regulated by phosphatidylinositol 3-kinase. Proc. Natl. Acad. Sci. U. S. A. 94:1997;7326-7330.
42. Mills I.G., Jones A.T., Clague M.J. Involvement of the endosomal autoantigen EEA1 in homotypic fusion of early endosomes. Curr. Biol. 8:1998;881-884.
43. Simonsen A., Lippé R., Christoforidis S., Gaullier J.M., Brech A., Callaghan J., Toh B.H., Murphy C., Zerial M., Stenmark H. EEA1 links PI (3) K function to Rab5 regulation of endosome fusion. Nature. 394:1998;494-498.
44. Rubino M., Miaczynska M., Lippé R., Zerial M. Selective membrane recruitment of EEA1 suggests a role in directional transport of clathrin-coated vesicles to early endosomes. J. Biol. Chem. 275:2000;3745-3748.
45. Lawe D.C., Chawla A., Merithew E., Dumas J., Carrington W., Fogarty K., Lifshitz L., Tuft R., Lambright D., Corvera S. Sequential roles for phosphatidylinositol 3-phosphate and Rab5 in tethering and fusion of early endosomes via their interaction with EEA1. J. Biol. Chem. 277:2002;8611-8617.
46. Gaullier J.M., Gillooly D., Simonsen A., Stenmark H. Regulation of endocytic membrane traffic by phosphatidylinositol 3-phosphate. Biochem. Soc. Trans. 27:1999;666-670.
47. Gaullier J.M., Ronning E., Gillooly D.J., Stenmark H. Interaction of the EEA1 FYVE finger with phosphatidylinositol 3-phosphate and early endosomes - role of conserved residues. J. Biol. Chem. 275:2000;24595-24600.
48. Waite R.L., Sentry J.W., Stenmark H., Toh B.H. Autoantibodies to a novel early endosome antigen 1. Clin. Immunol. Immunopathol. 86:1998;81-87.
49. Pierre P., Pepperkok R., Kreis T.E. Molecular characterization of two functional domains of CLIP-170 in vivo. J. Cell Sci. 107:1994;1909-1920.
50. Pierre P., Scheel J., Rickard J.E., Kreis T.E. CLIP-170 links endocytic vesicles to microtubules. Cell. 70:1992;887-900.
51. Goodson H.V., Skube S.B., Stalder R., Valetti C., Kreis T.E., Morrison E.E., Schroer T.A. CLIP-170 interacts with dynactin complex and the APC-binding protein EB1 by different mechanisms. Cell Motil. Cytoskeleton. 55:2003;156-173.
52. Diamantopoulos G.S., Perez F., Goodson H.V., Batelier G., Melki R., Kreis T.E., Rickard J.E. Dynamic localization of CLIP-170 to microtubule plus ends is coupled to microtubule assembly. J. Cell Biol. 144:1999;99-112.
53. Perez F., Diamantopoulos G.S., Stalder R., Kreis T.E. CLIP-170 highlights growing microtubule ends in vivo. Cell. 96:1999;517-527.
54. Dujardin D., Wacker U.I., Moreau A., Schroer T.A., Rickard J.E., De Mey J.R. Evidence for a role of CLIP-170 in the establishment of metaphase chromosome alignment. J. Cell Biol. 141(4):1998;849-862.
55. Scheel J., Pierre P., Rickard J.E., Diamantopoulos G.S., Valetti C., van der Groot F.G., Häner M., Aebi U., Kreis T.E. Purification and analysis of authentic CLIP-170 and recombinant fragments. J. Biol. Chem. 274:1999;25883-25891.
56. Schuyler S.C., Pellman D. Microtubule "plus-end-tracking proteins": the end is just the beginning. Cell. 105:2001;421-424.
57. Bell B.B., Tognoni P.G., Bihrle R. Limbic encephalitis as a paraneoplastic manifestation of renal cell carcinoma. J. Urol. 160:1998;828.
58. Wilson W.A., Gharavi A.E., Piette J.C. International classification criteria for antiphospholipid syndrome: synopsis of a post-conference workshop held at the Ninth International (Tours) aPL Symposium. Lupus. 10:2001;457-460.
59. Kobayashi T., Stang E., Fang K.S., de Moerloose P., Parton R.G., Gruenberg J. A lipid associated with the antiphospholipid syndrome regulates endosome structure and function. Nature. 392:1998;193-197.
60. Schmid S.L., Cullis P.R. Endosome marker is fat not fiction. Nature. 392:1998;135-136.
61. Raiborg C., Stenmark H. Hrs and endocytic sorting of ubiquitinated membrane proteins. Cell Struct. Funct. 27:2002;403-408.
62. Honey K., Rudensky A.Y. Lysosomal cysteine proteases regulate antigen presentation. Nat. Rev. Immunol. 3:2003;472-482.
63. Tervaert J.W., Mulder A.H., Kallenberg C.G. Perinuclear antineutrophil cytoplasmic antibodies (p-ANCA): clinical significance and relation to antibodies against myeloid lysosomal enzymes. Adv. Exp. Med. Biol. 336:1993;253-256.
64. Calafat J., Goldschmeding R., Ringeling P.L., Janssen H., van der Schoot C.E. In situ localization by double-labeling immunoelectron microscopy of anti-neutrophil cytoplasmic autoantibodies in neutrophils and monocytes. Blood. 75:1990;242-250.
65. Chang L., Savige J. Studies to demonstrate inhibition of functional activity of neutrophil lysosomal enzymes with ANCA. Adv. Exp. Med. Biol. 336:1993;97-100.
66. Kallenberg C.G., Tervaert J.W., van der Woude F.J., Goldschmeding R., dem Borne A.E., Weening J.J. Autoimmunity to lysosomal enzymes: new clues to vasculitis and glomerulonephritis? Immunol. Today. 12:1991;61-64.
67. Niles J.L., McCluskey R.T., Ahmad M.F., Arnaout M.A. Wegener's granulomatosus autoantigen is a novel neutrophil serine proteinase. Blood. 74:1989;1888-1893.
68. Manthorpe R., Permin H., Tage-Jensen U. Auto-antibodies in Sjögren's syndrome. With special reference to liver-cell membrane antibody (LMA). Scand. J. Rheumatol. 8:1979;168-172.
69. Selak S., Woodman R.C., Fritzler M.J. Autoantibodies to early endosome antigen (EEA1) produce a staining pattern resembling cytoplasmic anti-neutrophil cytoplasmic antibodies (C-ANCA). Clin. Exp. Immunol. 122:2000;493-498.
70. Wiik A. Testing for ANA and ANCA-diagnostic value and pitfalls. Rheumatology. 2003;Mosby, London.
71. Renier G., Fritzler M.J., Chevailler A. Golgi apparatus autoantibodies. Peter J.B., Shoenfeld Y. Autoantibodies. 1996;325-330 Elsevier, The Netherlands.
72. Barr F.A., Short B. Golgins in the structure and dynamics of the Golgi apparatus. Curr. Opin. Cell Biol. 15:2003;405-413.
73. Seelig H.P., Schranz P., Schroter H., Wiemann C., Renz M. Macrogolgin-A new 376 kD Golgi complex outer membrane protein as target of antibodies in patients with rheumatic diseases and HIV infections. J. Autoimmun. 7:1994;67-91.
74. Fritzler M.J., Hamel J.C., Ochs R.L., Chan E.K.L. Molecular characterization of two human autoantigens: unique cDNAs encoding 95- and 160-kD proteins of a putative family in the Golgi complex. J. Exp. Med. 178:1993;49-62.
75. Eystathioy T., Jakymiw A., Fujita D.J., Fritzler M.J., Chan E.K.L. Human autoantibody to a novel Golgi protein golgin-67: high similarity with golgin-95/gm 130 autoantigen. J. Autoimmun. 14:1999;179-187.
76. Seelig H.P., Schranz P., Schroter H., Wiemann C., Griffiths G., Renz M. Molecular genetic analyses of a 376-kilodalton Golgi complex membrane protein (Giantin). Mol. Cell. Biol. 14:1994;2564-2576.
77. Erlich R., Gleeson P.A., Campbell P., Dietzsch E., Toh B.-H. Molecular characterization of trans-Golgi p230. J. Biol. Chem. 271(14):1996;8328-8337.
78. Nakamura N., Rabouille C., Watson R., Nilsson T., Hui N., Slusarewicz P., Kreis T.E., Warren G. Characterization of a cis-Golgi matrix protein, GM130. J. Cell Biol. 131:1995;1715-1726.
79. Munro S., Nichols B.J. The GRIP domain - a novel Golgi-targeting domain found in several coiled-coil proteins. Curr. Biol. 9:1999;377-380.
80. Rodriquez J.L., Gelpi C., Thomson T.M., Real F.J., Fernandez J. Anti-Golgi complex antibodies in a patient with Sjögren's syndrome and lymphoma. Clin. Exp. Immunol. 49:1982;579-603.
81. Blaschek M.A., Pennec Y.L., Simitzis A.M., Le Goff P., Lamour A., Kerdraon G., Jouquan J., Youinou P. Anti-Golgi complex autoantibodies in patients with primary Sjögren's syndrome. Scand. J. Rheumatol. 17:1988;291-296.
82. Fritzler M.J., Etherington J., Sokoluk C., Kinsella T.D., Valencia D.W. Antibodies from patients with autoimmune disease react with a cytoplasmic antigen in the Golgi apparatus. J. Immunol. 132:1984;2904-2908.
83. Hong H.S., Morshed S.A., Tanaka S., Fujiwara T., Ikehara Y., Nishioka M. Anti-Golgi antibody in rheumatoid arthritis patients recognizes a novel antigen of 79 kDa (Doublet) by Western Blot. Scand. J. Immunol. 36:1993;785-792.
84. Rossie K.M., Piesco N.P., Charley M.R., Oddis C.V., Steen V.D., Fratto J., Deng J.S. A monoclonal antibody recognizing Golgi apparatus produced using affinity purified material from a patient with connective tissue disease. Scand. J. Rheumatol. 21:1992;109-115.
85. Mayet W.J., Hermann E., Csernok E., Knuth A. A human renal cancer line as a new antigen source for the detection of antibodies to cytoplasmic and nuclear antigens in sera of patients with Wegener's granulomatosis. J. Immunol. Methods. 143:1991;57-68.
86. Gentric A., Blaschek M., Julien C., Jouquan J., Pennec Y., Berthelot J.M., Mottier D., Casburn-Budd R., Youinou P. Nonorgan-specific autoantibodies in individuals infected with Type 1 human immunodeficiency virus. Clin. Immunol. Immunopathol. 59:1991;487-494.
87. Kooy J., Toh B.H., Gleeson P.A. Heterogeneity of human anti-Golgi auto-antibodies: reactivity with components from 35 to 260 kDa. Immunol. Cell Biol. 72:1994;123-127.
88. Bizzaro N., Pasini P., Ghirardello A., Finco B. High anti-Golgi autoantibody levels: an early sign of autoimmune disease? Clin. Rheumatol. 18:1999;346-348.
89. Nozawa K., Fritzler M.J., Von Mühlen C.A., Chan E.K.L. Giantin is the major Golgi autoantigen in human anti-Golgi complex sera. Arthritis Res. Ther. 2003;. (submitted for publication).
90. Keenan R.J., Freymann D.M., Stroud R.M., Walter P. The signal recognition particle. Annu. Rev. Biochem. 70(755-775):2001;755-775.
91. Andino R., Bartel E., Goodrich J., Gross C., Guthrie C., Maniatis T., Noller H., Sachs A., Varchavsky A., Weissman J., Wolin S. How cells read the genome: from DNA to protein. Alberts B., Johnson A., Lewis J., Raff M., Roberts K., Walter P. Molecular Biology of the Cell. 2002;299-374 Garland Scientific, New York.
92. Miller F.W. Signal recognition particle autoantibodies. Peter J.B., Shoenfeld Y. Autoantibodies. 1996;735-740 Elsevier, Amsterdam.
93. Wild K., Weichenrieder O., Strub K., Sinning I., Cusack S. Towards the structure of the mammalian signal recognition particle. Curr. Opin. Struct. Biol. 12:2002;72-81.
94. Rider L.G., Miller F.W. Laboratory evaluation of the inflammatory myopathies. Clin. Diagn. Lab. Immunol. 2:1995;1-9.
95. Targoff I.N., Johnson A.E., Miller F.W. Antibody to signal recognition particle in polymyositis. Arthritis Rheum. 33:1990;1361-1370.
96. Reeves W.H., Nigam S.K., Blobel G. Human autoantibodies reactive with the signal-recognition particle. Proc. Natl. Acad. Sci. U. S. A. 83:1986;9507-9511.
97. Kostova Z., Wolf D.H. For whom the bell tolls: protein quality control of the endoplasmic reticulum and the ubiquitin-proteasome connection. EMBO J. 22:2003;2309-2317.
98. Kruger E., Kuckelkorn U., Sijts A., Kloetzel P.M. The components of the proteasome system and their role in MHC class I antigen processing. Rev. Physiol., Biochem. Pharmacol. 2003.
99. Arribas J., Rodriguez M.L., Alvarez-DoForno R., Castano J.G. Autoantibodies against multicatalytic proteinase in patients with systemic lupus erythematosus. J. Exp. Med. 173:1991;423-427.
100. Feist E., Dörner T., Kuckelkorn U., Schmidtke G., Micheel B., Hiepe F., Burmester G.R., Kloetzel P.M. Proteasome α-type subunit C9 is a primary target of autoantibodies in sera of patients with myositis and systemic lupus erythematosus. J. Exp. Med. 184:1996;1313-1318.
101. Feist E., Kuckelkorn U., Dorner T., Donitz H., Scheffler S., Hiepe F., Kloetzel P.M., Burmester G.R. Autoantibodies in primary Sjögren's syndrome are directed against proteasomal subunits of the α and B type. Arthritis Rheum. 42:1999;697-702.
102. Egerer K., Kuckelkorn U., Rudolph P.E., Rückert J.C., Dörner T., Burmester G.R., Kloetzel P.M., Feist E. Circulating proteasomes are markers of cell damage and immunologic activity in autoimmune diseases. J. Rheumatol. 29:2002;2045-2052.
103. Mitchell P., Tollervey D. Musing on the structural organization of the exosome complex. Nat. Struct. Biol. 7:2000;843-846.
104. Van Hoof A., Parker R. The exosome: a proteasome for RNA? Cell. 99:1999;347-350.
105. Paushkin S., Gubitz A.K., Massenet S., Dreyfuss G. The SMN complex, an assemblyosome of ribonucleoproteins. Curr. Opin. Cell Biol. 14:2002;305-312.
106. Mukherjee D., Gao M., O'Connor J.P., Raijmakers R., Pruijn G., Lutz C.S., Wilusz J.R. The mammalian exosome mediates the efficient degradation of mRNAs that contain AU-rich elements. EMBO J. 21:2002;165-174.
107. Eystathioy T., Jakymiw A., Chan E.K.L., Séraphin B., Cougot N., Fritzler M.J. The GW182 protein co-localizes with mRNA degradation associated proteins hDcp1 and hLSm4 in cytoplasmic GW bodies. RNA. 9:2003;1171-1173.
108. Will C.L., Luhrmann R. Spliceosomal UsnRNP biogenesis, structure and function. Curr. Opin. Cell Biol. 13:2001;290-301.
109. Parry H.D., Scherly D., Mattaj I.W. 'Snurpogenesis': the transcription and assembly of U snRNP components. Trends Biol. Sci. 14:1989;15-19.
110. Yong J., Pellizzoni L., Dreyfuss G. Sequence-specific interaction of U1 snRNA with the SMN complex. EMBO J. 21:2002;1188-1196.
111. Massenet S., Pellizzoni L., Paushkin S., Mattaj I.W., Dreyfuss G. The SMN complex is associated with snRNPs throughout their cytoplasmic assembly pathway. Mol. Cell. Biol. 22:2002;6533-6541.
112. Pellizzoni L., Baccon J., Charroux B., Dreyfuss G. The survival of motor neurons (SMN) protein interacts with the snoRNP proteins fibrillarin and GAR1. Curr. Biol. 11:2001;1079-1088.
113. Pellizzoni L., Baccon J., Rappsilber J., Mann M., Dreyfuss G. Purification of native survival of motor neurons complexes and identification of Gemin6 as a novel component. J. Biol. Chem. 277:2002;7540-7545.
114. Baccon J., Pellizzoni L., Rappsilber J., Mann M., Dreyfuss G. Identification and characterization of Gemin7, a novel component of the survival of motor neuron complex. J. Biol. Chem. 277:2002;31957-31962.
115. Pellizzoni L., Yong J., Dreyfuss G. Essential role for the SMN complex in the specificity of snRNP assembly. Science. 298:2002;1775-1779.
116. Mourelatos Z., Dostie J., Paushkin S., Sharma A., Charroux B., Abel L., Rappsilber J., Mann M., Dreyfuss G. miRNPs: a novel class of ribonucleoproteins containing numerous microRNAs. Genes Dev. 16:2002;720-728.
117. Lefebvre S., Burglen L., Reboullet S., Clermont O., Burlet P., Viollet L., Benichou B., Cruaud C., Millasseau P., Zeviani M. Identification and characterization of a spinal muscular atrophy-determining gene. Cell. 80:1995;155-165.
118. Reinhart B.J., Bartel D.P. Small RNAs correspond to centromere heterochromatic repeats. Science. 297:2002;1831.
119. Carrington J.C., Ambros V. Role of microRNAs in plant and animal development. Science. 301:2003;336-338.
120. Hutvagner G., McLachlan J., Pasquinelli A.E., Balint E., Tuschl T., Zamore P.D. A cellular function for the RNA-interference enzyme Dicer in the maturation of the let-7 small temporal RNA. Science. 293:2001;834-838.
121. Tan E.M., Kunkel H.G. Characteristics of a soluble nuclear antigen precipitating with sera of patients with systemic lupus erythematosus. J. Immunol. 96:1966;464-471.
122. Lerner M.R., Steitz J.A. Antibodies to small nuclear RNAs complexed with proteins are produced by patients with systemic lupus erythematosus. Proc. Natl. Acad. Sci. U. S. A. 76:1979;5495-5499.
123. Ohosone Y., Mimori T., Griffith A., Akizuki M., Homma M., Craft J., Hardin J.A. Molecular cloning of cDNA encoding Sm autoantigen: derivation of a cDNA for a B polypeptide of the U series of small nuclear ribonucleoprotein particles. Proc. Natl. Acad. Sci. U. S. A. 86:1989;4249-4253.
124. Eystathioy T., Peebles C., Hamel J.C., Vaughan J.H., Chan E.K.L. Autoantibody to hLSm4 and the hepatameric LSm complex in anti-Sm sera. Arthritis Rheum. 46:2002;726-734.
125. Turley S.J., Tan E.M., Pollard K.M. Molecular cloning and sequence analysis of U3 snRNA-associated mouse fibrillarin. Biochim. Biophys. Acta. 1216:1993;119-122.
126. Arnett F.C., Reveille J.D., Goldstein R., Pollard K.M., Leaird K., Smith E.A., Carwile E.C., Fritzler M.J. Autoantibodies to fibrillarin in systemic sclerosis (scleroderma): an immunogenetic, serological and clinical analysis. Arthritis Rheum. 39:1996;1151-1160.
127. Hultman P., Pollard K.M. Fibrillarin autoantibodies. Peter J.B., Shoenfeld Y. Autoantibodies. 1996;253-259 Elsevier.
128. Arnett F.C., Reveille J.D., Valdez B.C. Autoantibodies to a nucleolar RNA helicase protein in patients with connective tissue disease. Arthritis Rheum. 40:1997;1487-1492.
129. Valdez B.C., Hening D., Busch R.K., Woods K., Flores-Rozas H., Hurwitz J., Perlaky L., Busch H. A nucleolar RNA helicase recognized by autoimmune antibodies from a patient with watermelon stomach. Nucleic Acids Res. 24:1996;1220-1224.
130. Raska I., Andrade L.E.C., Ochs R.L., Chan E.K.L., Chang C.-M., Roos G., Tan E.M. Immunological and ultrastructural studies of the nuclear coiled body with autoimmune antibodies. Exp. Cell Res. 195:1991;27-37.
131. Andrade L.E., Tan E.M., Chan E.K.L. Immunocytochemical analysis of the coiled body in the cell cycle and during cell proliferation. Proc. Natl. Acad. Sci. U. S. A. 90:1993;1947-1951.
132. Tucker K.E., Berciano M.T., Jacobs E.Y., LePage D.F., Shpargel K.B., Rossire J.J., Chan E.K., Lafarga M., Conlon R.A., Matera A.G. Residual Cajal bodies in coilin knockout mice fail to recruit Sm snRNPs and SMN, the spinal muscular atrophy gene product. J. Cell Biol. 154:2001;293-307.
133. Hiepe F. The particle nature of itnracellular antigens. Conrad K., Humbel R.-L., Meurer M., Shoenfeld Y., Tan E.M. Autoantigens and Autoantibodies: Diagnostic Tools and Clues to Our Understanding Autoimmunity. 2000;26-39 Pabst Science Publishers, Lengerich.
134. Brouwer R., Allmang C., Raijmakers R., van Aarssen Y., Egberts W.V., Petfalski E., Van Venrooij W.J., Tollervey D., Pruijn G.J. Three novel components of the human exosome. J. Biol. Chem. 276:2001;6177-6184.
135. Raijmakers R., Egberts W.V., Van Venrooij W.J., Pruijn G.J. The association of the human PM/Scl-75 autoantigen with the exosome is dependent on a newly identified N terminus. J. Biol. Chem. 278:2003;30698-30704.
136. Raijmakers R., Egberts W.V., Van Venrooij W.J., Pruijn G.J. Protein-protein interactions between human exosome components support the assembly of RNase PH-type subunits into a six-membered PNPase-like ring. J. Mol. Biol. 323:2002;653-663.
137. Wolfe J.F., Adelstein E., Sharp G.C. Antinuclear antibody with distinct specificity for polymositis. J. Clin. Invest. 59:1977;176-178.
138. Alderuccio F., Chan E.K.L., Tan E.M. Molecular characterization of an autoantigen of PM-Scl in the polymyositis/scleroderma overlap syndrome: a unique and complete human cDNA encoding an apparent 75-kD acidic protein of the nucleolus complex. J. Exp. Med. 173:1991.
139. Blüthner M., Bautz F.A. Cloning and characterization of the cDNA coding of a polymyositis-scleroderma overlap syndrome-related nucleolar 100-kD protein. J. Exp. Med. 176:1992;973-980.
140. Saira Mian I. Comparative sequence analysis of ribonucleases HII, III, II PH and D. Nucleic Acid Research. 25:1995;3187-3195.
141. Blüthner M., Bautz E.K.F., Bautz F.A. Mapping of epitopes recognized by PM/Scl autoantibodies with gene fragment phage display libraries. J. Immunol. Methods. 198:1996;187-198.
142. Oddis C.V., Targoff I.N. PM-Scl autoantibodies. Peter J.B., Shoenfeld Y. Autoantibodies. 1996;642-650 Elsevier, Amsterdam.
143. Raijmakers R., Renz M., Wiemann C., Vree Egberts W.T., Seelig H.P., Van Venrooij W.J., Pruijn G. PM/Scl-75 is the main autoantigen in patients with the polymyositis/scleroderma overlap syndrome. Arthritis Rheum. 2003;. (in press).
144. Byers P.H. Killing the messenger: new insights into nonsense-mediated mRNA decay. J. Clin. Invest. 109:2002;3-6.
145. Maquat L.E. Molecular biology-skiing toward nonstop mRNA decay. Science. 295:2002;2221-2222.
146. Long R.M., McNally M.T. mRNA decay: X (XRN1) marks the spot. Mol. Cell. 11:2003;1126-1128.
147. van Dijk E., Cougot N., Meyer S., Babajko S., Wahle E., Séraphin B. Human Dcp2: a catalytically active mRNA decapping enzyme located in specific cytoplasmic structures. EMBO J. 21:2002;6915-6924.
148. Tharun S., Parker R. Targeting an mRNA for decapping: displacement of translation factors and association of the Lsm1p-7p complex on deadenylated yeast mRNAs. Mol. Cell. 8:2001;1075-1083.
149. Ingelfinger D., Arndt-Jovin D.J., Luhrmann R., Achsel T. The human LSm1-7 proteins colocalize with the mRNA-degrading enzymes Dcp1/2 and Xrnl in distinct cytoplasmic foci. RNA. 8:2002;1489-1501.
150. Bouveret E., Rigaut G., Shevchenko A., Wilm M., Séraphin B. A Sm-like protein complex that participates in mRNA degradation. EMBO J. 19:2000;1661-1671.
151. Tharun S., He W., Mayes A.E., Lennertz P., Beggs J.D., Parker R. Yeast Sm-like proteins function in mRNA decapping and decay. Nature. 404:2000;515-518.
152. Dunckley T., Parker R. The DCP2 protein is required for mRNA decapping in Saccharomyces cerevisiae and contains a functional MutT motif. EMBO J. 18:1999;5411-5422.
153. Dunckley T., Parker R. Yeast mRNA decapping enzyme. Methods Enzymol. 342:2001;226-233.
154. Sheth U., Parker R. Decapping and decay of messenger RNA occur in cytoplasmic processing bodies. Science. 300:2003;805-808.
155. Wilusz C.J., Wang W., Peltz S.W. Curbing the nonsense: the activation and regulation of mRNA surveillance. Genes Dev. 15:2001;2781-2785.
156. Vasudevan S., Peltz S.W., Wilusz C.J. Non-stop decay - a new mRNA surveillance pathway. BioEssays. 24:2002;785-788.
157. Takizawa P.A., DeRisi J.L., Wilhelm J.E., Vale R.D. Plasma membrane compartmentalization in yeast by messenger RNA transport and a septin diffusion barrier. Johns Hopkins Univ. 290:2000;341-344.
158. Keene J.D., Tenenbaum S.A. Eukaryotic mRNPs may represent post-transcriptional operons. Mol. Cell. 9:2002;1161-1167.
159. Tenenbaum S.A., Lager P.J., Carson C.C., Keene J.D. Ribonomics: identifying mRNA subsets in mRNP complexes using antibodies to RNA-binding proteins and genomic arrays. Methods. 26:2002;191-198.
160. Schmitz M., Bachmann M., Laubinger J., Thijssen J.P., Pruijn G.J. Characterization of murine monoclonal antibodies against the Ro52 autoantigen. Clin. Exp. Immunol. 110:1997;53-62.
161. Kelekar A., Saitta M.R., Keene J.D. Molecular composition of Ro small ribonucleoprotein complexes in human cells: Intracellular localization of the 60- and 52-kD proteins. J. Clin. Invest. 93:1994;1637-1644.
162. Rhodes D.A., Ihrke G., Reinicke A.T., Malcherek G., Towey M., Isenberg D.A., Trowsdale J. The 52 000 MW Ro/SS-A autoantigen in Sjogren's syndrome/systemic lupus erythematosus (Ro52) is an interferon-gamma inducible tripartite motif protein associated with membrane proximal structures. Immunology. 106:2002;246-256.
163. Buyon J.P., Slade S.G., Reveille J.D., Hamel J.C., Chan E.K.L. Autoantibody responses to the "native" 52-kDa SS-A/Ro protein in neonatal lupus syndromes, systemic lupus erythematosus, and Sjögren's syndrome. J. Immunol. 152:1994;3675-3684.
164. Price C.M., McCarty G.A., Pettijohn D.E. NuMA protein is a human autoantigen. Arthritis Rheum. 27:1984;774-779.
165. Andrade L.E.C., Chan E.K.L., Peebles C.L., Tan E.M. Two major autoantigen-antibody systems of the mitotic spindle apparatus. Arthritis Rheum. 39:1996;1643-1653.
166. Yang C.H., Lambie E.J., Snyder M. NuMA: an unusually long coiled-coil related protein in the mammalian nucleus. J. Cell Biol. 116:1992;1303-1317.
167. Chou C.-H., Reeves W.H. Recognition of multiple epitopes in the coiled-coil domain of lamin B by human autoantibodies. Mol. Immunol. 29:1992;1055-1064.
168. Pollard K.M., Chan E.K.L., Grant B.J., Sullivan K.F., Tan E.M., Glass C.A. In vitro posttranslational modification of lamin B cloned from a human T-cell line. Mol. Cell. Biol. 10:1990;2164-2175.
169. Von Mühlen C.A., Chan E.K.L., Peebles C.L., Imai H., Kiyosawa K., Tan E.M. Non-muscle myosin as target antigen for human autoantibodies in patients with hepatitis C virus-associated chronic liver diseases. Clin. Exp. Immunol. 100:1995;67-74.
170. Reeves W.H., Pierani A., Chou C.H., Ng T., Nicastri C., Roeder R.G., Sthoeger Z.M. Epitopes of the p70 and p80 (ku) lupus autoantigens. J. Immunol. 146:1991;2678-2686.
171. Furneaux H.M., Dropcho E.J., Barbut D., Chen Y.-T., Rosenblum M.K., Old L.J., Posner J.B. Characterization of a cDNA encoding a 34 kd Purkinje neuron protein recognized by sera from patients with paraneoplastic ceberellar degeneration. Proc. Natl. Acad. Sci. U. S. A. 86:1989;2837-2877.
172. Doxsey S.J., Stein P., Evans L., Calarco P.D., Kirschner M. Pericentrin, a highly conserved centrosome protein involved in microtubule organization. Cell. 76:1994;639-650.
173. Bouckson-Castaing V., Moudjou M., Ferguson D.J.P., Mucklow S., Belkaid Y., Milon G., Crocker P.R. Molecular characterisation of ninein, a new coiled-coil protein of the centrome. J. Cell Sci. 109:1996;179-190.
174. Nozawa K., Fritzler M.J., Wood M.R., Chan E.K.L. Apoptotic bleb-independent clustering of Golgi complex and other cytoplasmic organelles during early apoptosis. 2003;. submitted for publication.
175. Nozawa K., Fritzler M.J., Hamel J.C., Chan E.K.L. Fragmentation of the Golgi complex and Golgi autoantigens during apoptosis and necrosis. Arthritis Res. 4 R3:2002.
176. Craft J., Hardin J.A. Linked sets of antinuclear antibodies: what do they mean? J. Rheumatol. 14:1987;106-109. (Suppl.).
177. Theofilopoulos A.N. The basis of autoimmunity: Part I. Mechanisms of aberrant self-recognition. Immunol. Today. 16:1995;90-98.
178. Reichlin M. Molecular definition of the Ro (SSA) particle(s): a frequent target of autoimmunity in systemic lupus erythematosus and Sjogren's Syndrome. Br. J. Rheumatol. 30:1991;58-62.
179. Tan E.M. Autoantibodies in diagnosis and identifying autoantigens. Immunologist. 7:1999;85-92.
180. Fox R.I., Chan E.K., Kang H.I. Laboratory evaluation of patients with Sjögren's syndrome. Clin. Biochem. 25:1992;213-222.
181. Reichlin M. Autoantibodies to the RoRNP particles. Clin. Exp. Immunol. 99:1995;7-9.
182. d/CENP-F in disorders associated with cell proliferation. J. Autoimmun. 8:1995;575-586.
183. Rattner J.B., Rees J., Whitehead C.M., Casiano C.A., Tan E.M., Humbel R.-L., Conrad K., Fritzler M.J. High frequency of neoplasia in patients with autoantibodies to centromere protein CENP-F. Clin. Invest. Med. 20:1997;308-319.
184. Dalmau J., Posner J.B. Neurological paraneoplastic syndromes. Springer Semin. Immunopathol. 18:1996;85-95.
185. Posner J.B., Dalmau J.O. Paraneoplastic syndromes affecting the central nervous system. Annu. Rev. Med. 48:1997;157-166.
186. Rutjes S.A., Vree Egberts W.T., Jongen P.H., Pruijn G., Van Venrooij J.V. Anti-Ro52 antibodies frequently co-occur with anti-Jo-1 antibodies in sera from patients with idiopathic inflammatory myopathy. Clin. Exp. Immunol. 109:1997;32-40.
187. Hueber W., Utz P., Steinman L., Robinson W. Autoantibody profiling for the study and treatment of autoimmune disease. Arthritis Res. 4:2002;290-295.
188. Scussel-Lonzetti L., Joyal F., Raynauld J.P., Roussin A., Rich É., Goulet J.R., Raymond Y., Senécal J.L. Predicting mortality in systemic sclerosis - analysis of a cohort of 309 French Canadian patients with emphasis on features at diagnosis as predictive factors for survival. Medicine. 81:2002;154-167.
189. Fritzler M.J., Schoenroth L.J. Advances in understanding and use of autoantibodies as markers of diseases. Sticherling M., Christophers E. Treatment of Autoimmune Diseases. 2003;29-42 Springer-Verlag, Wien.
190. Fritzler M.J. New technologies in the detection of autoantibodies. Conrad K., Fritzler M.J., Meurer M., Sack U., Shoenfeld Y. Autoantigens, Autoantibodies, Autoimmunity. 2002;50-63 Pabst Scientific Publishers, Lengerich.
191. Robinson W.H., Steinman L., Utz P.J. Proteomics technologies for the study of autoimmune disease. Arthritis Rheum. 46:2002;885-893.
192. Utz P.J. 21st European workshop for rheumatology research, Vienna, Austria, 1-4 March 2001. Arthritis Res. 3:2001;237-240.
193. Wiik A., Gordon T.P., Kavanaugh A.F., Lahita R.G., Reeves W.H., Van Venrooij W.J., Wilson M.R., Fritzler M.J. Cutting edge diagnostics in rheumatology: on the role of patients, clinicians and laboratory scientists in optimizing the use of autoimmune serology. Arthritis Care Res. 2003;. (in press).
194. Lupas A., Van Dyke M., Stock J. Predicting coiled coils from protein sequences. Science. 252:1991;1162-1164.
195. Andrade L.E., Chan E.K.L., Raska I., Peebles C.L., Roos G., Tan E.M. Human autoantibody to a novel protein of the nuclear coiled body immunological characteristics and cDNA cloning of p80-coilin. J. Exp. Med. 173:1991;1407-1419.
196. Schneider J., Presek P., Braun A., Bauer P., Konietzko N., Wiesner B., Woitowitz H.J. p53 protein, EGF receptor, and anti-p53 antibodies in serum from patients with occupationally derived lung cancer. Br. J. Cancer. 80:1999;1987-1994.
197. Miyachi K., Matsushima H., Hankins R.W., Hirakata M., Mimori T., Hosaka H., Amagasaki Y., Miyakawa H., Kako M., Shibata M., Onozuka Y., Ueno U. A novel antibody directed against a three-dimensional configuration of a 95-kDa protein in patients with autoimmune hepatic diseases. Scand. J. Immunol. 47:1998;63-68.
198. Galeazzi M., Morozzi G., Sebastiani G.D., Bellisai F., Marcolongo R., Cervera R., De Ramon G.E., Fernandez-Nebro A., Houssiau F., Jedryka-Goral A., Mathieu A., Papasteriades C., Piette J.C., Scorza R., Smolen J. Anti-neutrophil cytoplasmic antibodies in 566 European patients with systemic lupus erythematosus: prevalence, clinical associations and correlation with other autoantibodies. European concerted action on the immunogenetics of SLE. Clin. Exp. Rheumatol. 16:1998;541-546.